Background: Prior to receiving a drug from CCR5-antagonist class in HIV therapy, a patient must undergo an HIV tropism test to confirm that his or her viral population uses the CCR5 coreceptor for cellular entry, and not an alternative coreceptor. One approach to tropism testing is to examine the sequence of the V3 region of the HIV envelope, which interacts with the coreceptor.
Extraction:
At least 500 μL of blood plasma is needed as sample input for this genotypic HIV tropism test.
1. Extract HIV RNA from 500μL of plasma using an easyMAG (bioMérieux) automated extractor, or the preferred extraction method of your laboratory. Elute the extracted viral RNA into a 60 μL aliquot. Store at -20 degrees Celsius or begin Reverse Transcriptase-PCR immediately after extracting.
RT-PCR:
4μL of sample extract will be amplified in triplicate using nested RT-PCR methods. The RT-PCR reaction must be set up in a PCR-clean room.
1. Calculate the amount of reagent required for the number of samples to be amplified. Follow the table below indicating reagent volumes for 1 reaction.
Reagent Volume (μL) (1X reaction)
DEPC treated water 10.56 2x reaction buffer 20 50% sucrose and 0.04% bromophenol blue mix 4
Forward primer targeting the HIV V3 region 0.32 For a total of 19 μL per reaction. 2. In a PCR-clean room, using a repeater pipette, add 19 μL of reaction buffer per well to a clean PCR plate. 3. In a post amplification room, using an 8-channel multichannel pipette, transfer 1 μL of the RT-PCR template into the second-round PCR buffer. Change tips between each addition. 4. Cover the wells with PCR strip caps and transfer the second-round PCR plate to a thermocycler. 5. Set the thermocycler to run with the following program: 2 minutes at 94°C 35 cycles of (15 seconds at 94°C, 30 seconds at 55°C, 1 minute at 72°C) 7 minutes at 72°C 6. Remove plate from thermocycler after the temperature has returned to 25°C.
1. Prepare an agarose gel with 0.8 g of agarose powder in 50 mL of 1X TAE Buffer. Stir and melt in microwave for ~1 minute or until agarose is completely dissolved. 2. Add 6 μL of SYBR safe gel stain and swirl to mix. 3. Pour solution into a gel tray, and add enough gel combs to accommodate the number of PCR wells. 4. Once the gel is dry, remove combs and place the gel in the gel apparatus, making sure it is completely submerged in 1X TAE buffer. 5. Using a 10 μL multichannel pipette, add 8μL of each PCR sample to its own well in the gel. Cover the PCR plate after the amplifications have been added to the gel. 6. Add 6 μL of DNA ladder to at least one well per row. 7. Run the gel apparatus at ~100V for ~10 minutes, making sure that the bands do not run off the gel. 8. Place the gel onto a UV trans-illuminator and take a picture of the gel.
Wells with PCR-amplified DNA will appear light, indicating a successful amplification. 9. Make note of all samples where three amplifications were success. If necessary, repeat RT-PCR for those samples with fewer than 3 amplifications.
Proceed to sequencing
Sequencing:
After having amplified viral cDNA, samples can be prepared for sequencing. The sequencing reaction should take place in a post-amplification room.
1. Remove BigDye from the freezer and sequencing primers from the refrigerator. Let the BigDye thaw at room temperature, for no longer than 1 hour. Table 3 . Reagent volumes required for 1 reaction of sequencing. *Note: prepare a separate mix for each primer. **Note: the BigDye Buffer used in the sequencing reaction can be prepared as follows: Mix 17.5 mL of Trizma hydrochloride buffer solution (1 M) (pH9.0) and 0.125 mL of Magnesium Chloride (1 M). Bring the final volume to 100 mL with reagent grade water. This should be stored at 2-8° C. 3. Using the calculations from 3.3, prepare the sequencing reaction mixes for each primer and vortex for no more than 5 seconds. Aliquot into 0.2mL strip tubes. 4. Aliquot 5 μL of sequencing reaction mix into the appropriate plate wells using a multichannel pipette. Cover the plate(s) containing sequencing reaction mix with a Kimwipe and set aside. 5. Prepare a 1:15 dilution of amplified PCR product by adding 180 μL of Baxter sterile water to the remaining PCR product. 6. Pipette 1 μL of the diluted sample to the bottom of the appropriate plate wells, change pipette tips. 7. When finished transferring sample, seal the plate with strip caps and vortex for 1 second 8. Place the plate in a centrifuge. Set the speed to 145g, when the spin speed reaches 145g, stop the spin. 9. Place the plate in a thermocycler(s) set to the following program: 25 cycles of (10 sec.@ 96° C, 5 sec. @ 50° C, 55 sec. @ 60° C) The volume should be at least 6μL. The cycle should take roughly 1.2 hours.
Proceed to precipitation
Precipitation:
To "clean-up" the viral cDNA following the sequencing reaction, perform ethanol precipitation using 95% ethanol.
1. Retrieve plate from the thermocycler and bring to a post-amplification room. 2. Remove strip caps and place them in order on a clean paper towel or Kimwipe.
3. Pipette 4μL of Working EDTA-Sodium Acetate Solution to the side of each sample well. Tap the plate gently so that the EDTA-Sodium solution falls to the bottom of the well. The same tips may be used so long as they do not contact the sample at the bottom of the well. 5. Seal the caps and vortex the plate for 10 seconds. Tap the plate to dislodge any bubbles. 6. Place the plate in the freezer at -20°C for a minimum of 30 minutes and a maximum of 2 hours. 7. a. Once precipitation has occurred, remove the plate from the freezer and place in a centrifuge for 20 minutes at 3700 rpm. b. Remove the appropriate amount of Hi-Di Formamide (Applied Biosystems) from the freezer to allow it to thaw before denaturation.
*Note: Denaturation of a full 96-well plate requires 960μL of HiDi Formamide and thus it is advantageous to prepare ~1.1mL aliquots beforehand. 8. After spinning the plate remove and discard the strip caps. Invert the plate over the waste container (eg. garbage bin) and decant the supernatant. Rid of any remaining supernatant by blotting the inverted plates on paper towel. 9. Fold 2 sheets of paper towel and place on the surface of the plate. Place the plate facedown in the centrifuge and spin at 145g, stopping the spin when it reaches 145g. 10. Remove the plate from the centrifuge and check to be sure wells are empty. Pipette 155μL of chilled 95% ethanol into the wells. 11. Discard the supernatant into the waste container and blot on paper towel and repeat the centrifugation in 4.10. 12. Upon removing the plate from the centrifuge, discard used paper towel and let plate stand face up for 2-5 minutes to allow any remaining ethanol to evaporate.
Proceed to denaturing 7. Denaturing 1. Retrieve the thawed HiDi Formamide and decant into a container large enough for a multichannel pipette, *Note: If using pre-aliquoted measures as noted in 6.7b, one tube is required for each 96-well plate to be run. 2. Using a multichannel pipette, distribute 10μL of HiDi Formamide into all wells on the plate, including those that are empty. 3. Cover the plate with a septa mat to form a seal. 4. Place the plate in a thermocycler at 90°C for 2 minutes. 5. Following denaturation, place the plate in a plate holder then load into the sequencer. Upload a prepared sequencing layout. Plates can be kept at -20°C for up to one week before performing the sequencing run.
Analyzing the Resultant Data using Base Calling Software.
1. Using ReCall perform automatic base calling with no human intervention, single primer coverage is acceptable. ReCall is a custom base calling software that can be found at the following URL: http://pssm.cfenet.ubc.ca/ *Note: An account is required to login. To set up an account, click the "Register" button at the login page. Once an account has been created you may access the upload page. 2. When logged in, you may select sample files for upload. Using the browse option you can locate your raw sequencing data for upload with a maximum upload of 20Mb. *Note: Web Recall will only accept data files as ABI and SCF files in a .zip, .tar or .tar.gz file 3. Once files for upload have been selected, choose your reference sequence. In this case, be sure the reference sequence is set to 'V3.' You are now ready to click "Process Data." 4. Processed data will appear on the right hand side of the page under the heading "Past Samples." Each run or sample set processed will be placed in a folder labeled with the date. These can be re-labeled by clicking the "Rename" button. 5. Clicking on the folder will bring up a list of samples. Those that are red have failed; those that are green have passed. By clicking on a specific sample and the "View" button, you are able to review the sequence. Follow the instructions on the right side of the page to navigate through the sequence. *Note: For this method, it is acceptable to export sequences which pass recall (shown in green) automatically, without manual intervention. 6. If you are satisfied with the results you can choose to download the passing sequences by clicking "Download." Files will be downloaded in a zipped folder. *Note: under "Settings" you can select download and email options, including file type. 7. Samples failing to produce clean triplicate sequences should be reamplified in triplicate from extract. If RePCR fails to provide a clean sequence, a minimum of 2 sequences is acceptable for use in tropism inference.
9. Inferring Viral Tropism from Sequences Generated by Population-based Sequencing using the Geno2pheno Co-receptor Algorithm.
Representative Results
When the protocol is performed correctly one should expect to successfully sequence 2 or 3 replicates for each sample. Negatives run alongside samples should have no indication of RNA. The majority of sequences should "pass" basecalling by ReCall.
Based on the distribution of R5 and non-R5 within the community viral population, the majority of randomly selected patient samples would be expected to have R5-using virus. Therefore unless the project design would suggest otherwise, one should expect to have more R5 than non-R5 samples. 
Discussion
The method presented here is a standard sequencing method applied to tropism testing. The clinical application of HIV envelope V3 loop sequencing to predict viral tropism has until late been limited. This method has been shown, in retrospective analyses of the maraviroc (ViiV Healthcare) clinical trials, to be at minimum equally able to predict viral tropism in comparison to other validated assays used clinically.
There are many benefits to performing genotypic analysis of the V3 loop for tropism prediction. First and foremost, this procedure can be performed at any facility with operational sequencing equipment, greatly increasing the accessibility and reducing the turnaround time of tropism testing. In comparison, the phenotypic Enhanced Sensitivity Trofile Assay (ESTA) (Monogram Biosciences), which has served as the gold standard for tropism testing, is performed at one centre in Southern California. Additional benefits include the requirement of less starting material and a minimum required plasma viral load of 500copies/mL. As well, the operational costs of running the genotypic assay are relatively low in comparison to those of a phenotypic assay. The use of the ReCall software in particular eliminates the requirement for manual sequence review, which tends to be a labour intensive part of genotype analyses.
The method presented here is fairly straightforward, with no particular step outweighing another in importance. We do suggest running PCR and sequencing in triplicate to increase the odds of capturing minority species within the viral population of a sample. Replicates greater than three can be performed, however we have found triplicates to be both efficient and reliable. We also suggest using the One-Step Reverse Transcriptase PCR Kit (Qiagen) which performs both RT-PCR and first round PCR in the same reaction while maintaining high sensitivity and specificity.
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